<VariationArchive VariationID="846957" VariationName="NM_004562.3(PRKN):c.337_376del (p.Pro113fs)" VariationType="Deletion" Accession="VCV000846957" Version="22" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-29" DateCreated="2020-04-15" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="831746" VariationID="846957">
      <GeneList>
        <Gene Symbol="PRKN" FullName="parkin RBR E3 ubiquitin protein ligase" GeneID="5071" HGNC_ID="HGNC:8607" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q26</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="161347417" stop="162727766" display_start="161347417" display_stop="162727766" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="161768589" stop="163148833" display_start="161768589" display_stop="163148833" Strand="-" />
          </Location>
          <OMIM>602544</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004562.3(PRKN):c.337_376del (p.Pro113fs)</Name>
      <CanonicalSPDI>NC_000006.12:162262560:CAGTGTGCAGAATGACAGCCAGCCCCACAGAGTCTCCTGG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q26</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="162262561" stop="162262600" display_start="162262561" display_stop="162262600" variantLength="40" positionVCF="162262560" referenceAlleleVCF="TCAGTGTGCAGAATGACAGCCAGCCCCACAGAGTCTCCTGG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="162683593" stop="162683632" display_start="162683593" display_stop="162683632" variantLength="40" positionVCF="162683592" referenceAlleleVCF="TCAGTGTGCAGAATGACAGCCAGCCCCACAGAGTCTCCTGG" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>p.Pro113Thrfs*51</Name>
      </OtherNameList>
      <ProteinChange>P113fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.162683593_162683632del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.162683593_162683632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.162262561_162262600del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.162262561_162262600del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008289.2" sequenceAccession="NG_008289" sequenceVersion="2" change="g.470203_470242del">
            <Expression>NG_008289.2:g.470203_470242del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004562.3" sequenceAccession="NM_004562" sequenceVersion="3" change="c.337_376del" MANESelect="true">
            <Expression>NM_004562.3:c.337_376del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004553.2" sequenceAccession="NP_004553" sequenceVersion="2" change="p.Pro113fs">
            <Expression>NP_004553.2:p.Pro113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013987.3" sequenceAccession="NM_013987" sequenceVersion="3" change="c.337_376del">
            <Expression>NM_013987.3:c.337_376del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054642.2" sequenceAccession="NP_054642" sequenceVersion="2" change="p.Pro113fs">
            <Expression>NP_054642.2:p.Pro113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013988.3" sequenceAccession="NM_013988" sequenceVersion="3" change="c.171+180710_171+180749del">
            <Expression>NM_013988.3:c.171+180710_171+180749del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="771529549" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00010" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00011" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00016" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        <AlleleFrequency Value="0.00016" Source="The Genome Aggregation Database (gnomAD)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004562.3(PRKN):c.337_376del (p.Pro113fs) AND not provided" Accession="RCV001050394" Version="25">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-26" SubmissionCount="5">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004562.3(PRKN):c.337_376del (p.Pro113fs) AND Autosomal recessive juvenile Parkinson disease 2" Accession="RCV001809967" Version="12">
        <ClassifiedConditionList TraitSetID="1942">
          <ClassifiedCondition DB="MedGen" ID="C1868675">Autosomal recessive juvenile Parkinson disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-06-28" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004562.3(PRKN):c.337_376del (p.Pro113fs) AND multiple conditions" Accession="RCV002479309" Version="8">
        <ClassifiedConditionList TraitSetID="81982">
          <ClassifiedCondition DB="MedGen" ID="C1868675">Autosomal recessive juvenile Parkinson disease 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0242379">Lung cancer</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0919267">Ovarian neoplasm</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-26" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2020-04-15" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10072423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12114481</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12730996</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15090472</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15197707</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15390068</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16769863</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18413468</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19351622</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19636047</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19891003</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21996382</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22956510</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23818421</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31147223</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31324919</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301651</ID>
          <ID Source="BookShelf">NBK1478</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-27">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="81982" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="5713" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplasm of ovary</ElementValue>
                <XRef ID="123843001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ovarian Neoplasms</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ovarian neoplasm</ElementValue>
                <XRef ID="HP:0100615" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0021068" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ovarian tumor</ElementValue>
                <XRef ID="HP:0100615" DB="Human Phenotype Ontology" />
                <XRef ID="123843001" DB="SNOMED CT" />
              </Name>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2012">
                <ID Source="PubMed">22964825</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2013">
                <ID Source="PubMed">23188549</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2021">
                <ID Source="PubMed">33410258</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2018">
                <ID Source="PubMed">29450531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg122</URL>
                <CitationText>UK NICE Clinical guideline (CG122), Ovarian cancer: recognition and initial management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer, 2024</CitationText>
              </Citation>
              <XRef ID="C0919267" DB="MedGen" />
              <XRef ID="D010051" DB="MeSH" />
              <XRef ID="MONDO:0021068" DB="MONDO" />
              <XRef Type="primary" ID="HP:0100615" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="3274" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Juvenile Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive juvenile Parkinson disease 2</ElementValue>
                <XRef ID="MONDO:0010820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Early-Onset Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease autosomal recessive, early onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile parkinsonism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism, early onset, with diurnal fluctuation</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PDJ</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK2</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Parkin type of early-onset Parkinson disease (PARK-Parkin) is characterized by the cardinal signs of Parkinson disease (PD): bradykinesia, resting tremor, and rigidity. The median age at onset is 31 years (range: 3-81 years). The disease is slowly progressive: disease duration of more than 50 years has been reported. Clinical findings vary; hyperreflexia is common. Lower-limb dystonia may be a presenting sign and cognitive decline appears to be no more frequent than in the general population. Dyskinesia as a result of treatment with levodopa frequently occurs.</Attribute>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9642" />
                <XRef ID="9642" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301651</ID>
                <ID Source="BookShelf">NBK1478</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="2828" DB="Orphanet" />
              <XRef ID="C1868675" DB="MedGen" />
              <XRef ID="MONDO:0010820" DB="MONDO" />
              <XRef Type="MIM" ID="600116" DB="OMIM" />
            </Trait>
            <Trait ID="54641" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Malignant tumor of lung</ElementValue>
                <XRef ID="363358000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lung cancer, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lung cancer</ElementValue>
                <XRef ID="MONDO:0008903" DB="MONDO" />
              </Name>
              <Citation Type="general" Abbrev="CAP/IASLC/AMP, 2018">
                <ID Source="PubMed">29398453</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng122</URL>
                <CitationText>UK NICE guideline NG122, Lung cancer: diagnosis and management, 2023</CitationText>
              </Citation>
              <XRef ID="C0242379" DB="MedGen" />
              <XRef ID="MONDO:0008903" DB="MONDO" />
              <XRef Type="MIM" ID="211980" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1942" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3274" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Juvenile Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive juvenile Parkinson disease 2</ElementValue>
                <XRef ID="MONDO:0010820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Early-Onset Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease autosomal recessive, early onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile parkinsonism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism, early onset, with diurnal fluctuation</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PDJ</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK2</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Parkin type of early-onset Parkinson disease (PARK-Parkin) is characterized by the cardinal signs of Parkinson disease (PD): bradykinesia, resting tremor, and rigidity. The median age at onset is 31 years (range: 3-81 years). The disease is slowly progressive: disease duration of more than 50 years has been reported. Clinical findings vary; hyperreflexia is common. Lower-limb dystonia may be a presenting sign and cognitive decline appears to be no more frequent than in the general population. Dyskinesia as a result of treatment with levodopa frequently occurs.</Attribute>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9642" />
                <XRef ID="9642" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301651</ID>
                <ID Source="BookShelf">NBK1478</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="2828" DB="Orphanet" />
              <XRef ID="C1868675" DB="MedGen" />
              <XRef ID="MONDO:0010820" DB="MONDO" />
              <XRef Type="MIM" ID="600116" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2379875" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="267267|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001214498" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10072423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301651</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22956510</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19636047</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro113Thrfs*51) in the PRKN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRKN are known to be pathogenic (PMID: 10072423, 20301651, 22956510). This variant is present in population databases (rs771529549, gnomAD 0.03%). This premature translational stop signal has been observed in individual(s) with Parkinson disease (PMID: 19636047). ClinVar contains an entry for this variant (Variation ID: 846957). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.162683593_162683632del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4033191" SubmissionDate="2021-12-21" DateLastUpdated="2022-01-15" DateCreated="2022-01-15">
        <ClinVarSubmissionID localKey="NM_004562.2:c.337_376del|OMIM:600116" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002059555" DateUpdated="2022-01-15" DateCreated="2022-01-15" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.337_376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10812468</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4045240" SubmissionDate="2022-01-24" DateLastUpdated="2022-01-29" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_004562.2(PARK2):c.337_376del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002064119" DateUpdated="2022-01-29" DateCreated="2022-01-29" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the PARK2 gene demonstrated a 40 base pair deletion in exon 3, c.337_376del. This deletion results in an amino acid frameshift and creates a premature stop codon 50 amino acids downstream of the mutation, p.Pro113Thrfs*51. This deletion is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated PARK2 protein with potentially abnormal function. This deletion has been previously described in a patient with a gross deletion of exons 3 and 4 on the other allele (PMID: 19891003). This patient presented with early onset Parkinsonism and developed dopamine dysregulation syndrome (DDS) as a consequence of rotigotine therapy. Other deletions in the PARK2 gene have also been described in several patients with PARK2-related disorders (PMID: 19715670). This sequence change has been described in the gnomAD database with a low population frequency of 0.026%in non-Finnish European subpopulation (dbSNP rs771529549) ; however it has not been observed in homozygous state in any individuals. These collective evidences indicate that this sequence change is likely pathogenic, however functional studies have not been performed to prove this conclusively.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.337_376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2905138" SubmissionDate="2022-12-27" DateLastUpdated="2022-12-31" DateCreated="2021-01-26">
        <ClinVarSubmissionID localKey="A15500|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001475992" DateUpdated="2022-12-31" DateCreated="2021-01-26" Type="SCV" Version="2" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31147223</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19891003</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23818421</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15090472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15197707</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15266615</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15390068</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16769863</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18413468</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19351622</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21996382</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19636047</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12114481</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12730996</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.337_376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
          <SubmissionName>SUB8819545</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3255235" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2021-05-28">
        <ClinVarSubmissionID localKey="NM_004562.3:c.337_376del|OMIM:167000;211980;600116" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001652820" DateUpdated="2022-12-31" DateCreated="2021-05-28" Type="SCV" Version="2" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.3:c.337_376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="167000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="211980" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
          <SubmissionName>SUB9694437</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4009349" SubmissionDate="2023-06-28" DateLastUpdated="2023-07-01" DateCreated="2022-01-01">
        <ClinVarSubmissionID localKey="GDXSV:277200" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002043908" DateUpdated="2023-07-01" DateCreated="2022-01-01" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Also known as 438_477del using alternate nomenclature; This variant is associated with the following publications: (PMID: 11971093, 19891003, 26556299, 19636047, 23818421, 24375549, 28672806, 31324919)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:3808434</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.337_376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_200_20230628054203</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_78_20211229054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7895453" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1727700|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004227006" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21996382</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23818421</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31147223</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31324919</ID>
          </Citation>
          <Comment>PM2, PM3, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004562.3:exon 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Pro113Thrfs*51</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.3:c.337_376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7131465" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="6c2159559c8037dcfc3eb84402fd67d3a42c1aefe5e75bb99ebe6f930fb9ef23|OMIM:600116" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003826649" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.3:c.337_376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4009349" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255235" TraitType="Disease" MappingType="XRef" MappingValue="167000" MappingRef="OMIM">
        <MedGen CUI="C1140680" Name="Ovarian cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2379875" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7895453" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255235" TraitType="Disease" MappingType="XRef" MappingValue="211980" MappingRef="OMIM">
        <MedGen CUI="C0242379" Name="Lung cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4045240" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4033191" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7131465" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255235" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2905138" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

